ENTREP1 and breast carcinoma: Because low expression of ENTREP significantly impacts the long‐term prognosis of breast cancer patients, the target substrates regulated by the ENTREP‐E3 ligase system as well as the molecular mechanism underlying the downregulation of ENTREP would be crucial for further understanding of the biology of breast cancer.